White Biotechnology Market Size, Share, and Trends 2025 to 2034

The white biotechnology market is witnessing steady growth as industries adopt bio-based alternatives to reduce environmental impact. Valued at USD 264.63 billion in 2025, the market is projected to surpass USD 397.69 billion by 2034, growing at a CAGR of 4.63% amid rising demand for eco-friendly solutions, government incentives, and advancements in AI-powered bioprocessing.

Last Updated : August 2025  |  Report Code : 5009  |  Category : Chemical and Material  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on White Biotechnology Market 

5.1. COVID-19 Landscape: White Biotechnology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global White Biotechnology Market, By Type

8.1. White Biotechnology Market, by Type

8.1.1. Biofuels

8.1.1.1. Market Revenue and Forecast

8.1.2. Biomaterials

8.1.2.1. Market Revenue and Forecast

8.1.3. Biochemicals

8.1.3.1. Market Revenue and Forecast

8.1.4. Industrial enzymes

8.1.4.1. Market Revenue and Forecast  

Chapter 9. Global White Biotechnology Market, By Application

9.1. White Biotechnology Market, by Application

9.1.1. Bioenergy

9.1.1.1. Market Revenue and Forecast

9.1.2. Pharmaceuticals

9.1.2.1. Market Revenue and Forecast

9.1.3. Food & Beverages

9.1.3.1. Market Revenue and Forecast

9.1.4. Feed

9.1.4.1. Market Revenue and Forecast

 

9.1.5. Other Applications

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global White Biotechnology Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Type

10.1.2. Market Revenue and Forecast, by Application

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Type

10.1.3.2. Market Revenue and Forecast, by Application

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Type

10.1.4.2. Market Revenue and Forecast, by Application

10.2. Europe

10.2.1. Market Revenue and Forecast, by Type

10.2.2. Market Revenue and Forecast, by Application

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Type

10.2.3.2. Market Revenue and Forecast, by Application

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Type

10.2.4.2. Market Revenue and Forecast, by Application

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Type

10.2.5.2. Market Revenue and Forecast, by Application

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Type

10.2.6.2. Market Revenue and Forecast, by Application

10.3. APAC

10.3.1. Market Revenue and Forecast, by Type

10.3.2. Market Revenue and Forecast, by Application

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Type

10.3.3.2. Market Revenue and Forecast, by Application

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Type

10.3.4.2. Market Revenue and Forecast, by Application

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Type

10.3.5.2. Market Revenue and Forecast, by Application

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Type

10.3.6.2. Market Revenue and Forecast, by Application

10.4. MEA

10.4.1. Market Revenue and Forecast, by Type

10.4.2. Market Revenue and Forecast, by Application

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Type

10.4.3.2. Market Revenue and Forecast, by Application

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Type

10.4.4.2. Market Revenue and Forecast, by Application

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Type

10.4.5.2. Market Revenue and Forecast, by Application

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Type

10.4.6.2. Market Revenue and Forecast, by Application

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Type

10.5.2. Market Revenue and Forecast, by Application

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Type

10.5.3.2. Market Revenue and Forecast, by Application

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Type

10.5.4.2. Market Revenue and Forecast, by Application

Chapter 11. Company Profiles

11.1. EUCODIS Bioscience GmbH

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Dupont De Nemours Inc. 

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Koninklijke DSM NV

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. BASF SE

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Evonik Industries AG

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Lonza Group Ltd

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Laurus Labs

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Corbion NV

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Novozymes

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Archer Daniels Midland Company

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global white biotechnology market size is expected to increase USD 397.69 billion by 2034 from USD 252.92 billion in 2024.

The white biotechnology market is anticipated to grow at a CAGR of over 4.63% between 2025 and 2034.

The major players operating in the white biotechnology market are EUCODIS Bioscience GmbH, Dupont De Nemours Inc., Koninklijke DSM NV, BASF SE, Evonik Industries AG, Lonza Group Ltd, Laurus Labs, Corbion NV, Novozymes, Archer Daniels Midland Company, and Others.

The driving factor of the white biotechnology market is the increasing demand for sustainable products.

North America region will lead the global white biotechnology market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client